Table 2.

SBs mononuclear metal complexes with antimalarial, antioxidant, antidiabetic, and anti-Alzheimer activities.

Structure	Compound	% Inhibition, MIC, and IC50	K i	Ref
	Zn(BZ-PCBPMP)2 (20)	MIC = 0.56 μmol/L (P. falciparum)	-	Shaikh et al., 2022 [74]
	Fe(III) complex (21)	% inhib: 65.54% (antimalarial) % inhib: 52–54% (α-amylase) % inhib: 94.27% (DPPH)	-	Ragole et al., 2022 [75]
	22	IC50 = 12.45 µM (AChE) IC50 = 9.61 µM (BChE) IC50 = 35.57 µM (α-glycosidase)	Ki = 11.92 ± 3.90 µM (AChE) Ki = 6.98 ± 0.96 µM (BChE) Ki = 38.17 ± 6.26 µM (α-glycosidase)	Şenocak et al., 2021 [76]
	23	IC50 = 7.24 µM (AChE) IC50 = 4.73 µM (BChE) IC50 = 30.84 µM (α-glycosidase)	Ki = 6.26 ± 0.83 µM (AChE) Ki = 3.68 ± 0.54 µM (BChE) Ki = 37.14 ± 7.12 µM (α-glycosidase)	Şenocak et al., 2021 [76]
	24	IC50 = 18.06 µM (AChE) IC50 = 11.25 µM (BChE) IC50 = 26.21 µM (α-glycosidase)	Ki = 15.73 ± 4.73 µM (AChE) Ki = 10.27 ± 1.68 µM (BChE) Ki = 30.50 ± 3.82 µM (α-glycosidase)	Şenocak et al., 2021 [76]
	25	IC50 = 1.41 ± 0.03 μmol/mL (α-amylase) IC50 = 0.62 ± 0.07 μmol/mL (α-glucosidase)	-	Deswal et al., 2022 [78]
	26	IC50 = 1.33 ± 0.05 μmol/mL (α-amylase) IC50 = 0.60 ± 0.05 μmol/mL (α-glucosidase)	-	Deswal et al., 2022 [78]